NexImmune, Inc. · LSX:A3EUTV

NexImmune, Inc. financial statements

NexImmune, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2023FY2022FY2021FY2020FY2019FY2018
Revenue000000
Cost of revenue1.02M1.50M870.3K619.0K436.4K204.6K
Gross profit-1.02M-1.50M-870.3K-619.0K-436.4K-204.6K
Research and development18.3M47.1M37.5M17.8M15.2M8.00M
Selling, general and administrative13.0B15.9M15.8M10.0M5.71M5.24M
Operating income-29.2M-63.1M-53.3M-27.9M-20.9M-13.2M
Depreciation and amortization1.02M994.8K870.3K619.0K436.4K204.6K
EBITDA-28.2M-62.1M-52.4M-27.2M-20.4M-13.0M
Interest expense576.7M905.3K1.68M7.26K0
Income before tax-32.3M-62.5M-50.9M-29.9M-20.5M-12.8M
Income tax-2-576.7M843.9K1.77M-246.8K409.2K
Net income-32.3M514.2M-51.7M-31.6M-20.3M-12.8M
Earnings per share, basic-30.82534.29-56.67-34.76-22.53-14.25

Balance sheet

LineFY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents3.20M34.6M30.3M5.03M9.13M426.0K
Short-term investments1.44M051.5M1.01B1.01M11.6M
Receivables74.5K6.42K73.6K
Inventory-19.5K61.1K
Current assets5.40M37.4M86.3M8.39M11.0M12.3M
Property, plant and equipment5.43M4.43M2.89M2.58M1.70M
Total assets8.59M43.1M91.0M11.3M13.7M14.1M
Accounts payable1.34M2.38M1.05M2.76M1.17M860.7K
Current liabilities5.08M10.3M7.22M27.0M3.03M3.00M
Total debt68.8K1.02M19.1M53.6M35.0M
Total liabilities5.08M10.8M7.27M27.1M3.11M3.33M
Shareholders' equity3.51M32.3M83.8M-15.8M10.6M10.8M
Shares outstanding1.05M962.4K913.2K910.3K900.9K900.9K

Cash flow

LineFY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations-31.4M-51.2M-45.8M-26.4M-19.4M-11.1M
Capital spending-48.7K-1.26M-2.35M-864.7K-1.25M-937.8K
Free cash flow-31.5M-52.4M-48.1M-27.3M-20.7M-12.1M
Cash from investing-44.5K50.3M-53.8M221.9K9.42M-12.6M
Cash from financing05.18M124.9M22.1M18.8M9.18M
Dividends paid-377.6K
Change in cash-31.5M4.30M25.3M-4.10M8.77M-14.6M